Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Alexander

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Kidney International. Supplement|October 16, 2004
Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathyCharles M Alexander, Paulette A Lyle, William F Keane, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 22, 2005
Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of controlRichard M Bergenstal, Soma S Nag, Jane E B Reusch, et al.
Diabetes Care|March 1, 2006
Treatment escalation and rise in HbA1c following successful initial metformin therapyGregory A Nichols, Charles M Alexander, Cynthia J Girman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 9, 2009
Economic and clinical impact of inpatient diabetic hypoglycemiaSuellen M Curkendall, Jaime L Natoli, Charles M Alexander, et al.
Patient Preference and Adherence|February 12, 2015
Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetesKaan Tunceli, Changgeng Zhao, Michael J Davies, et al.
Medical Care|April 28, 2006
The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patientsKathleen A Foley, Margo A Denke, Sachin Kamal-Bahl, et al.
The American Journal of Cardiology|July 5, 2003
Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic eventsKathleen A Foley, Ross J Simpson, John R Crouse, et al.
Diabetes Care|February 28, 2004
Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care settingSarah J Beaton, Soma S Nag, Margaret J Gunter, et al.
Diabetes Research and Clinical Practice|November 16, 2010
Use of the UKPDS Outcomes Model to predict all-cause mortality in U.S. adults with type 2 diabetes mellitus: comparison of predicted versus observed mortalityMay Song, Charles M Alexander, Panagiotis Mavros, et al.
BMC Cardiovascular Disorders|August 20, 2004
Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional studyMark W Massing, Kathleen A Foley, Lori Carter-Edwards, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Kidney International. Supplement|October 16, 2004
Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathyCharles M Alexander, Paulette A Lyle, William F Keane, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 22, 2005
Macrovascular risk factors in patients with diabetes: physician treatment strategies and extent of controlRichard M Bergenstal, Soma S Nag, Jane E B Reusch, et al.
Diabetes Care|March 1, 2006
Treatment escalation and rise in HbA1c following successful initial metformin therapyGregory A Nichols, Charles M Alexander, Cynthia J Girman, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 9, 2009
Economic and clinical impact of inpatient diabetic hypoglycemiaSuellen M Curkendall, Jaime L Natoli, Charles M Alexander, et al.
Patient Preference and Adherence|February 12, 2015
Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetesKaan Tunceli, Changgeng Zhao, Michael J Davies, et al.
Medical Care|April 28, 2006
The impact of physician attitudes and beliefs on treatment decisions: lipid therapy in high-risk patientsKathleen A Foley, Margo A Denke, Sachin Kamal-Bahl, et al.
The American Journal of Cardiology|July 5, 2003
Effectiveness of statin titration on low-density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic eventsKathleen A Foley, Ross J Simpson, John R Crouse, et al.
Diabetes Care|February 28, 2004
Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care settingSarah J Beaton, Soma S Nag, Margaret J Gunter, et al.
Diabetes Research and Clinical Practice|November 16, 2010
Use of the UKPDS Outcomes Model to predict all-cause mortality in U.S. adults with type 2 diabetes mellitus: comparison of predicted versus observed mortalityMay Song, Charles M Alexander, Panagiotis Mavros, et al.
BMC Cardiovascular Disorders|August 20, 2004
Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional studyMark W Massing, Kathleen A Foley, Lori Carter-Edwards, et al.
Pageof 5